指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

ARDS临床实践指南2021

ARDS Clinical Practice Guideline 2021.
指南 / 共识 · J Intensive Care · 2022-07-08
一句话结论日本三学会联合发布的ARDS指南2021:成人限制潮气量4-8 mL/kg(GRADE 1D)、推荐使用低剂量激素(GRADE 1B)、建议对重症ARDS实施ECMO(GRADE 2B)。

该指南由日本重症医学会、日本呼吸学会和日本呼吸治疗学会联合委员会制定,在2016版基础上新增15个儿童临床问题,共包含46个成人临床问题和15个儿童临床问题。方法学采用系统评价和GRADE系统,并新增诊断准确性Meta分析和网状Meta分析。成人推荐包括:限制潮气量4-8 mL/kg(GRADE 1D)、使用低剂量激素(GRADE 1B)、建议对重症ARDS实施ECMO(GRADE 2B)、不建议常规以跨肺压指导PEEP设置(GRADE 2B)等。儿童推荐包括:不建议使用无创呼吸支持(GRADE 2D)、建议中重度ARDS俯卧位(GRADE 2D)等。

要点

  • 成人ARDS机械通气推荐限制潮气量至4-8 mL/kg(GRADE 1D)。
  • 成人ARDS推荐使用低剂量激素(GRADE 1B),不建议使用高剂量激素(GRADE 2C)。
  • 重症ARDS建议实施体外膜氧合(GRADE 2B)。
  • 不建议常规以跨肺压作为PEEP设置的依据(GRADE 2B);不建议以血清CRP和降钙素原识别细菌性肺炎为 underlying disease(GRADE 2D)。
  • 儿童ARDS不建议使用无创呼吸支持(无创正压通气/经鼻高流量氧疗)(GRADE 2D);建议中重度ARDS患儿俯卧位(GRADE 2D);不建议常规NO吸入(GRADE 2C);不建议每日镇静中断(GRADE 2D)。

适用人群与场景

  • 成人ARDS患者(46个临床问题)及儿童ARDS患者(15个临床问题)。

处置流程与药物剂量

  • 成人ARDS机械通气:推荐限制潮气量至4-8 mL/kg(GRADE 1D)。
  • 成人ARDS激素:推荐使用低剂量激素(GRADE 1B);不建议使用高剂量激素(GRADE 2C)。
  • 成人ARDS氧合目标:不建议以过低SpO2(PaO2)为目标的管理(GRADE 2D)。
  • 成人ARDS PEEP设置:不建议常规以跨肺压作为依据(GRADE 2B)。
  • 重症ARDS:建议实施体外膜氧合(GRADE 2B)。
  • 成人ARDS病原识别:不建议使用血清C反应蛋白和降钙素原识别细菌性肺炎为 underlying disease(GRADE 2D)。
  • 儿童ARDS呼吸支持:不建议使用无创呼吸支持(无创正压通气/经鼻高流量氧疗)(GRADE 2D);不建议常规实施NO吸入治疗(GRADE 2C)。
  • 儿童中重度ARDS:建议俯卧位(GRADE 2D);儿童呼吸衰竭不建议每日镇静中断(GRADE 2D)。

研究设计与关键结果

  • 制定机构:日本重症医学会/日本呼吸学会/日本呼吸治疗学会联合委员会;方法:系统评价结合GRADE系统及推荐强度确定方法,新增诊断准确性Meta分析和网状Meta分析;共46个成人临床问题和15个儿童临床问题。

证据类型、等级与局限

  • 证据类型:临床实践指南;采用GRADE分级系统;各推荐条目后标注GRADE等级(1D、1B、2B、2C、2D等)。

对床旁实践的改变

  • 成人ARDS机械通气应限制潮气量至4-8 mL/kg(GRADE 1D)。
  • 成人ARDS推荐使用低剂量激素(GRADE 1B),不建议高剂量激素(GRADE 2C)。
  • 重症ARDS建议考虑ECMO(GRADE 2B)。
  • 不建议常规以跨肺压指导PEEP设置(GRADE 2B)。
  • 儿童ARDS不建议使用无创呼吸支持(GRADE 2D),中重度建议俯卧位(GRADE 2D),不建议常规NO吸入(GRADE 2C),不建议每日镇静中断(GRADE 2D)。

指南或共识出处

  • ARDS Clinical Practice Guideline 2021,日本重症医学会/日本呼吸学会/日本呼吸治疗学会联合委员会发布。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The joint committee of the Japanese Society of Intensive Care Medicine/Japanese Respiratory Society/Japanese Society of Respiratory Care Medicine on ARDS Clinical Practice Guideline has created and released the ARDS Clinical Practice Guideline 2021.

METHODS: The 2016 edition of the Clinical Practice Guideline covered clinical questions (CQs) that targeted only adults, but the present guideline includes 15 CQs for children in addition to 46 CQs for adults. As with the previous edition, we used a systematic review method with the Grading of Recommendations Assessment Development and Evaluation (GRADE) system as well as a degree of recommendation determination method. We also conducted systematic reviews that used meta-analyses of diagnostic accuracy and network meta-analyses as a new method.

RESULTS: Recommendations for adult patients with ARDS are described: we suggest against using serum C-reactive protein and procalcitonin levels to identify bacterial pneumonia as the underlying disease (GRADE 2D); we recommend limiting tidal volume to 4-8 mL/kg for mechanical ventilation (GRADE 1D); we recommend against managements targeting an excessively low SpO2 (PaO2) (GRADE 2D); we suggest against using transpulmonary pressure as a routine basis in positive end-expiratory pressure settings (GRADE 2B); we suggest implementing extracorporeal membrane oxygenation for those with severe ARDS (GRADE 2B); we suggest against using high-dose steroids (GRADE 2C); and we recommend using low-dose steroids (GRADE 1B). The recommendations for pediatric patients with ARDS are as follows: we suggest against using non-invasive respiratory support (non-invasive positive pressure ventilation/high-flow nasal cannula oxygen therapy) (GRADE 2D), we suggest placing pediatric patients with moderate ARDS in the prone position (GRADE 2D), we suggest against routinely implementing NO inhalation therapy (GRADE 2C), and we suggest against implementing daily sedation interruption for pediatric patients with respiratory failure (GRADE 2D).

CONCLUSIONS: This article is a translated summary of the full version of the ARDS Clinical Practice Guideline 2021 published in Japanese (URL: https://www.jsicm.org/publication/guideline.html ). The original text, which was written for Japanese healthcare professionals, may include different perspectives from healthcare professionals of other countries.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Tasaka S, Ohshimo S, Takeuchi M, et al. ARDS Clinical Practice Guideline 2021. J Intensive Care. 2022. PMID: 35799288. doi:10.1186/s40560-022-00615-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。